AI assistant
AtriCure, Inc. — Director's Dealing 2013
Jan 15, 2013
31802_dirs_2013-01-15_e185cc9f-97db-4111-94ed-e3bb2dca594e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2013-01-14
Reporting Person: Seith Douglas J (SVP of Sales and Marketing)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 52648 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $1.52 | 2014-03-01 | Common Stock (5263) | Direct | |
| Incentive Stock Option (right to buy) | $11.63 | 2015-04-06 | Common Stock (1513) | Direct | |
| Incentive Stock Option (right to buy) | $12.00 | 2015-08-05 | Common Stock (2631) | Direct | |
| Incentive Stock Option (right to buy) | $11.06 | 2016-02-08 | Common Stock (5000) | Direct | |
| Non-Qualified Stock Option (right to buy) | $9.70 | 2016-12-06 | Common Stock (250) | Direct | |
| Non-Qualified Stock Option (right to buy) | $12.22 | 2017-02-08 | Common Stock (200) | Direct | |
| Non-Qualified Stock Option (right to buy) | $10.10 | 2018-05-28 | Common Stock (1500) | Direct | |
| Non-Qualified Stock Option (right to buy) | $10.05 | 2018-07-30 | Common Stock (10000) | Direct | |
| Non-Qualified Stock Option (right to buy) | $5.70 | 2018-10-28 | Common Stock (512) | Direct | |
| Non-Qualified Stock Option (right to buy) | $6.27 | 2022-10-25 | Common Stock (21100) | Direct | |
| Non-Qualified Stock Option (right to buy) | $6.73 | 2022-12-27 | Common Stock (100000) | Direct |
Footnotes
F1: Includes 32,500 shares of unvested restricted stock awarded under the AtriCure, Inc. 2005 Equity Incentive Plan, which vest 25% annually over four years from date of grant.
F2: The option vests and is exercisable as to 25% of the shares on the first four anniversaries of the grant date.
F3: The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.